Landmark celebration of the Indian Pharma Industry as the 10th edition of CPhI & P-MEC India gets underway

CPhI & P-MEC 2016 at a glance:

· 1,300 exhibitors, a 100 plus countries’ participation and above 40,000 attendees in a marquee show spanning a week

· Held concurrently at two different venues, BEC and BKC

· Salient features include Supplier-Finder Desk, Innovation Gallery and Exhibitor Showcase

Mumbai, November 22, 2016: The Indian pharmaceutical industry saw the launch of the grand 10th anniversary edition of UBM India’s signature event, CPhI & P-MEC India 2016, one of the world’s leading pharma networking expos. To celebrate the landmark, this year’s edition of CHhI & P-MEC expo is being held between November 21 and 23 in Mumbai – for the first time, at two concurrent venues – The Bombay Exhibition Centre (BEC) while it also made its debut at the MMRDA Grounds, Bandra Kurla Complex (BKC).

This year’s marquee event saw more than 1,300 exhibitors, a 100 plus countries’ participation and above 40,000 attendees. While BEC had traditional participants for CPhI & P-MEC; the concurrent venue at MMRDA Grounds, BKC also included participants for ICSE & BioPh.

The inauguration of CPhI-P-MEC 2016 occured parallely at both the venues in the presence of an august gathering of industry leaders including Dr. Appaji – Director General Pharmexcil; Mr. Ravi Uday Bhaskar – Additional Executive Director Pharmexcil; and Mr. Satish Wagh – Vice Chariman Chemexcil & CMD Supriya Lifesciences; among others.

To mark a decade’s existence of its flagship pharma event, UBM India previously launched the India Pharma Week (IPW), an attractive platter of tentrend-setting events that got off to a flying start on November 17, prior to the CPhI & P-MEC expo. Focusing on the pillars of business, knowledge, leadership, innovation, recognition and networking in the pharma domain, the IPW included a Pre-Connect Congress; Women in Pharma – Power Breakfast; the India Pharma Awards; Networking Evening; Pharma Leaders’ Golf; a closed door CEO Roundtable and many more activities. The IPW transformed the CPhI & P-MEC exhibition from a wall-bound show to one with considerable intellectual value addition.

Originating from CPhI Worldwide, the CPhI & P-MEC India was first introduced in 2006. Today, it has become South Asia’s leading pharma meeting place, covering every step of the supply chain, from drug discovery to finished dosage. CPhI India is an industry platform encompassing CROs, CMOs and manufacturers of API, Generics, Excipients and Drug formulation, Fine chemicals, Biosimilars, Finished Formulations, Lab chemicals and Biotechnology. P-MEC, on the other hand, includes manufacturers of Pharma Machinery and Equipment, Analytical Equipment, Automation & Robotics, Packaging Equipment & Supplies, Plant/Facility Equipment, Automation & Controls, Processing Equipment, RFID, Tableting / Capsule fillers, Clean room equipment, Filling equipment and Laboratory products.

The show has grown exponentially over the years, with domestic and foreign exhibitors and visitors engaging over significant levels of business. This year, the expo comprised exciting facets such as the Supplier-Finder Desk (a digital floor plan that enabled visitors find exhibitors based on services or company names), Innovation Gallery (an arena where participating pharma companies were encouraged to showcase innovations on an international platform) and Exhibitor Showcase (a platform where exhibitors demonstrated how their new product launches are going to be efficacious.)

The key companies exhibiting in the 2016 edition at CPhI include Hetero Limited; Nectar Lifesciences Limited; Alembic Pharmaceuticals Limited; Glenmark Pharmaceuticals Ltd. and Aurobindo Pharma Ltd., among others. On the other hand, some of the leading companies such as ACG Worldwide; Shimadzu Analytical; Gansons Ltd; Fette GmbH and Accupack Engineering Pvt Ltd will exhibit at P-MEC.

According to ongoing research, India is among the fastest-growing pharmaceutical markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the industry a definite competitive advantage. The Indian pharma industry has a strong global foothold with accounting for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms, and is expected to expand at $55 billion by 2020. Moreover, generic drugs account for 20 percent of global exports in terms of volume, making the country the largest provider of generic medicines globally. This number is expected to grow even further in the coming years.

Mr. Yogesh Mudras, Managing Director, UBM India said, “CPhI & P-MEC India 2016 is perfectly placed to provide a most comprehensive industry platform for every company that deals with pharmaceuticals in India. With it completing a decade in the industry, the expo gave us time to look back, revaluate, and move ahead. He added, “For the future, we believe that India has a strong potential to become a hub for biopharmaceutical innovation. The time has come for it to emerge as an innovator nation in this sector and play a leading role in collaborative research in bio pharmaceuticals.”

Corporate Comm India(CCI Newswire)